On 07/06/2012 11:10 AM, Lin MD, Simon wrote:

It would be interesting to see a link from the drugs to genes for DNA testing on the FDA label:

http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm

This interest has been expressed by some of my colleagues here at Pitt as well. Looking at the webpage, it looks like the drug column uses UNII preferred terms and the label sections use standard syntax. Not sure what is used for the string names in the biomarker and therapeutic area columns but they look easy to map - can someone hazard a guess? Once we know that, I could script a database table from the html table of ucm083378.htm and create mappings to the referenced sections in LinkedSPL for drug products containing the active moieties listed in the Drug column. Would interested folks please provide a use case that I will use along with the use case for my colleagues to make the mapping immediately useful?

best,
-Rich

Best regards,

Simon

==================================================

Simon Lin, MD

Director, Biomedical Informatics Research Center

Marshfield Clinic Research Foundation

1000 N Oak Ave, Marshfield, WI 54449

Office 715-221-7299

lin.si...@mcrf.mfldclin.edu

www.marshfieldclinic.org/birc

For scheduling assistance, please contact

      Crystal Gumz, Administrative Secretary

      gumz.crys...@mcrf.mfldclin.edu

      715-221-6403

*From:*Richard Boyce [mailto:rd...@pitt.edu]
*Sent:* Friday, July 06, 2012 9:41 AM
*To:* public-semweb-lifesci@w3.org
*Subject:* FYI: rxnorm mappings in LinkedSPLs

FYI - for those interested in a linked version of US drug product labeling, I added mappings to RxNORM for active moieties and drug products in the FDA product label data served by LinkedSPLs (http://tinyurl.com/7hyd44g). The mappings go to the Purls served by the Bioportal SPARQL endpoint. Active moieties are mapped using the dailymed:activeMoietyRxCUI property while product mappings use dc:subject. Importantly, SPLs for products containing multiple active moieties (e.g., http://tinyurl.com/78hu8l3) and multiple dose forms (e.g., http://tinyurl.com/7987rjh) seem to be handled correctly. I plan to add drug class mappings w/in the next two weeks. Feedback and suggestions are quite welcome.

kind regards,
-Rich Boyce



--
Richard Boyce, PhD
Assistant Professor of Biomedical Informatics
Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and 
Training Program
Scholar, Comparative Effectiveness Research Program
University of Pittsburgh
rd...@pitt.edu  <mailto:rd...@pitt.edu>
412-648-9219 (W), 206-371-6186 (C)
Twitter: @bhaapgh

------------------------------------------------------------------------
The contents of this message may contain private, protected and/or privileged information. If you received this message in error, you should destroy the e-mail message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained within. Please contact the sender and advise of the erroneous delivery by return e-mail or telephone. Thank you for your cooperation.


--
Richard Boyce, PhD
Assistant Professor of Biomedical Informatics
Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and 
Training Program
Scholar, Comparative Effectiveness Research Program
University of Pittsburgh
rd...@pitt.edu
412-648-9219 (W), 206-371-6186 (C)
Twitter: @bhaapgh

Reply via email to